Lexaria Bioscience (LEXX) Non-Current Assets (2011 - 2026)

Lexaria Bioscience has disclosed Non-Current Assets across 16 years of filings, most recently posting $717021.0 for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $717021.0, down 24.77% year-over-year; the trailing twelve-month figure through Feb 2026 was $717021.0 (down 24.77% YoY), and the FY2025 annual result was $706776.0, down 27.12% from the prior year.
• Non-Current Assets came in at $717021.0 for Q1 2026 at Lexaria Bioscience, up from $687678.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.0 million in Q2 2023 to a low of $687678.0 in Q4 2025.
• The 5-year median for Non-Current Assets is $925058.0 (2024), against an average of $877517.3.
• Across the five-year window, Non-Current Assets slumped 31.29% in 2022 and gained 18.63% in 2023, its largest moves.
• Lexaria Bioscience's Non-Current Assets stood at $854110.0 in 2022, then increased by 9.25% to $933140.0 in 2023, then climbed by 3.74% to $968033.0 in 2024, then declined by 28.96% to $687678.0 in 2025, then advanced by 4.27% to $717021.0 in 2026.
• The last three Non-Current Assets figures came in at $717021.0 (Q1 2026), $687678.0 (Q4 2025), and $706776.0 (Q3 2025), per Business Quant data.